(Q33867776)

29 July 2017

1 reference

title

Therapeutic plasma exchange and cytapheresis in pediatric patients (English)

1 reference

29 July 2017

Gorlin JB

1

1 reference

29 July 2017

1 August 1999

1 reference

29 July 2017

1 reference

29 July 2017

21

1 reference

29 July 2017

1

1 reference

29 July 2017

21-39

1 reference

The IBM Blood Cell Separator and Blood Cell Processor: a personal perspective

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Clinical evaluation of a flat-plate membrane plasma exchange system

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Excess mortality after human albumin administration in critically ill patients. Clinical and pathophysiological evidence suggests albumin is harmful

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Transfusion medicine. First of two parts--blood transfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Central venous catheters for apheresis access

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Femoral vascular access for large-volume collection of peripheral blood progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Clinical collection and use of peripheral blood stem cells in pediatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Analysis of venous access for therapeutic plasma exchange in patients with neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Pediatric large volume peripheral blood progenitor cell collections from patients under 25 kg: a primer

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Unexpected citrate toxicity and severe hypocalcemia during apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Prevention of citrate reactions during therapeutic plasma exchange by constant infusion of calcium gluconate with the return fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Intensive plasma exchange in small and critically ill pediatric patients: techniques and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Complications of plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Complications of therapeutic plasma exchange: a recent assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Frequency of immediate adverse effects associated with therapeutic apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

ACE inhibitors and LDL-apheresis with dextran sulphate adsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Physician coverage of therapeutic apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

An overview of current management

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Pathogenesis and treatment of sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Priapism as a complication of sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Blood exchange [correction of exchance]-a rescue procedure for complicated falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Apheresis for severe malaria complicated by cerebral malaria, acute respiratory distress syndrome, acute renal failure, and disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Therapeutic apheresis for babesiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Haemodynamic effects of haematocrit reduction in patients with polycythaemia secondary to cyanotic congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Treatment of high-risk, refractory acquired methemoglobinemia with automated red blood cell exchange.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Frequency of early death in children with acute leukemia presenting with hyperleukocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Pulmonary leukostasis without hyperleukocytosis: a clinicopathologic study of 16 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Reversible respiratory failure due to intravascular leukostasis in chronic myelogenous leukemia. Relationship of oxygen transfer to leukocyte count

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Rapid cytoreduction in childhood leukemic hyperleukocytosis by conservative therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

When is the optimum time to harvest peripheral blood stem cells in children following standard dose chemotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Mobilization of peripheral blood stem cells in children using G-CSF after carboplatin containing myelosuppressive chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Single institution experience with mobilization, harvesting, and reinfusion of peripheral blood stem cells in children with a solid tumor or leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Peripheral blood progenitor cell collection by large-volume leukapheresis in low-weight children

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Large-volume leukapheresis in pediatric patients: processing more blood diminishes the apparent magnitude of intra-apheresis recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Sustained cytopenia after leukapheresis for collection of peripheral blood stem cells in small children

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Complications of peripheral blood stem cell harvesting: review of 554 PBSC leukaphereses

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

PBSC collection following 67Ga infusion for a nuclear medicine study

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

White cell transfusions born again

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Granulocyte transfusions. Time for a second look

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Treatment of severe cardiac allograft rejection with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Plasma exchange and prednisone in Guillain-Barré syndrome: a controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Guillain-Barré syndrome in children

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Treatment of Guillain-Barré syndrome with high-dose gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Plasmapheresis in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Long-term effects of repeated plasma exchange in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Plasmapheresis in a pregnancy complicated by acute systemic lupus erythematosis. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Successful plasmapheresis in corticosteroid-resistant hemolysis in infectious mononucleosis: role of autoantibodies against triosephosphate isomerase

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Successful use of plasma exchange in a child with refractory immune hemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Immunohematologic consequences of major ABO-mismatched bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

ABO-incompatible marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Antibodies linked to rare epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Plasmapheresis treatment in patients with severe atopic keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Plasma and whole blood exchange in meningococcal sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Haemolytic uraemic syndrome: therapeutic effect of plasma infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Moschcowitz, multimers, and metalloprotease.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Effective removal of copper by plasma exchange in fulminant Wilson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Protein A immunoadsorption treatment in hematology: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Treatment of refractoriness to platelet transfusion by protein A column therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Treatment of congenital and acquired hemophilia patients by extracorporeal removal of antibodies to coagulation factors: a review of US clinical studies 1987-1990. Hemophilia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2899%2900064-8

7 January 2021

10.1016/S0955-3886(99)00064-8

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10724782